APA (7th ed.) Citation

KW, C., B, M., C, M., JZ, L., TH, E., J, R., . . . DM, S. (2025). Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial. The Journal of infectious diseases, 231(1), 131. https://doi.org/10.1093/infdis/jiae501

Chicago Style (17th ed.) Citation

KW, Chew, et al. "Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial." The Journal of Infectious Diseases 231, no. 1 (2025): 131. https://doi.org/10.1093/infdis/jiae501.

MLA (9th ed.) Citation

KW, Chew, et al. "Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial." The Journal of Infectious Diseases, vol. 231, no. 1, 2025, p. 131, https://doi.org/10.1093/infdis/jiae501.